Association between glucagonlike peptide 1 receptor agonist and sodium–glucose cotransporter 2 inhibitor use and covid-19 outcomes

Anna R. Kahkoska, Trine Julie Abrahamsen, G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa A. Haendel, Klara R. Klein, Hemalkumar Mehta, Joshua D. Miller, Richard A. Moffitt, Til Stüurmer, Kajsa Kvist, John B. Buse

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Association between glucagonlike peptide 1 receptor agonist and sodium–glucose cotransporter 2 inhibitor use and covid-19 outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences